ArticleFuture science OA2026

A comprehensive analysis of the adverse drug events of metastatic and unresectable gastrointestinal stromal tumor treatment options: avapritinib, imatinib, regorafenib, ripretinib, and sunitinib safety insights and implications.

Cameron M Thompson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.